Literature DB >> 22169407

Investigating tumor perfusion and metabolism using multiple hyperpolarized (13)C compounds: HP001, pyruvate and urea.

Cornelius von Morze1, Peder E Z Larson, Simon Hu, Hikari A I Yoshihara, Robert A Bok, Andrei Goga, Jan Henrik Ardenkjaer-Larsen, Daniel B Vigneron.   

Abstract

The metabolically inactive hyperpolarized agents HP001 (bis-1,1-(hydroxymethyl)-[1-(13)C]cyclopropane-d(8)) and urea enable a new type of perfusion magnetic resonance imaging based on a direct signal source that is background-free. The addition of perfusion information to metabolic information obtained by spectroscopic imaging of hyperpolarized [1-(13)C]pyruvate would be of great value in exploring the relationship between perfusion and metabolism in cancer. In preclinical normal murine and cancer model studies, we performed both dynamic multislice imaging of the specialized hyperpolarized perfusion compound HP001 (T(1)=95 s ex vivo, 32 s in vivo at 3 T) using a pulse sequence with balanced steady-state free precession and ramped flip angle over time for efficient utilization of the hyperpolarized magnetization and three-dimensional echo-planar spectroscopic imaging of urea copolarized with [1-(13)C]pyruvate, with compressed sensing for resolution enhancement. For the dynamic data, peak signal maps and blood flow maps derived from perfusion modeling were generated. The spatial heterogeneity of perfusion was increased 2.9-fold in tumor tissues (P=.05), and slower washout was observed in the dynamic data. The results of separate dynamic HP001 imaging and copolarized pyruvate/urea imaging were compared. A strong and significant correlation (R=0.73, P=.02) detected between the urea and HP001 data confirmed the value of copolarizing urea with pyruvate for simultaneous assessment of perfusion and metabolism. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22169407      PMCID: PMC3393100          DOI: 10.1016/j.mri.2011.09.026

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  27 in total

1.  Imaging of blood flow using hyperpolarized [(13)C]urea in preclinical cancer models.

Authors:  Cornelius von Morze; Peder E Z Larson; Simon Hu; Kayvan Keshari; David M Wilson; Jan Henrik Ardenkjaer-Larsen; Andrei Goga; Robert Bok; John Kurhanewicz; Daniel B Vigneron
Journal:  J Magn Reson Imaging       Date:  2011-03       Impact factor: 4.813

2.  Lung tumors evaluated with FDG-PET and dynamic CT: the relationship between vascular density and glucose metabolism.

Authors:  Ukihide Tateishi; Hiroshi Nishihara; Eriko Tsukamoto; Toshiaki Morikawa; Nagara Tamaki; Kazuo Miyasaka
Journal:  J Comput Assist Tomogr       Date:  2002 Mar-Apr       Impact factor: 1.826

3.  High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas.

Authors:  H J Aronen; F S Pardo; D N Kennedy; J W Belliveau; S D Packard; D W Hsu; F H Hochberg; A J Fischman; B R Rosen
Journal:  Clin Cancer Res       Date:  2000-06       Impact factor: 12.531

4.  Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy.

Authors:  David A Mankoff; Lisa K Dunnwald; Julie R Gralow; Georgiana K Ellis; Aaron Charlop; Thomas J Lawton; Erin K Schubert; Jeffrey Tseng; Robert B Livingston
Journal:  J Nucl Med       Date:  2002-04       Impact factor: 10.057

5.  Molecular imaging with endogenous substances.

Authors:  Klaes Golman; Jan H Ardenkjaer-Larsen; J Stefan Petersson; Sven Mansson; Ib Leunbach
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-20       Impact factor: 11.205

6.  The relationship between vascular and metabolic characteristics of primary breast tumours.

Authors:  Scott I K Semple; Fiona J Gilbert; Thomas W Redpath; Roger T Staff; Trevor S Ahearn; Andrew E Welch; Steven D Heys; Andrew W Hutcheon; Elizabeth H Smyth; Shailesh Chaturvedi
Journal:  Eur Radiol       Date:  2004-08-14       Impact factor: 5.315

7.  Cerebral perfusion assessment by bolus tracking using hyperpolarized 13C.

Authors:  E Johansson; S Månsson; R Wirestam; J Svensson; J S Petersson; K Golman; F Ståhlberg
Journal:  Magn Reson Med       Date:  2004-03       Impact factor: 4.668

8.  Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR.

Authors:  Jan H Ardenkjaer-Larsen; Björn Fridlund; Andreas Gram; Georg Hansson; Lennart Hansson; Mathilde H Lerche; Rolf Servin; Mikkel Thaning; Klaes Golman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-20       Impact factor: 11.205

9.  Hyperpolarized 13C MR angiography using trueFISP.

Authors:  Jonas Svensson; Sven Månsson; Edvin Johansson; J Stefan Petersson; Lars E Olsson
Journal:  Magn Reson Med       Date:  2003-08       Impact factor: 4.668

10.  Relationships between oxygen and glucose metabolism in human liver tumours: positron emission tomography using (15)O and (18)F-deoxyglucose.

Authors:  Ken-ichiro Fukuda; Hiroki Taniguchi; Toshimori Koh; Satoshi Kunishima; Hisakazu Yamagishi
Journal:  Nucl Med Commun       Date:  2004-06       Impact factor: 1.690

View more
  31 in total

1.  A 2DRF pulse sequence for bolus tracking in hyperpolarized 13C imaging.

Authors:  Shuyu Tang; Wenwen Jiang; Hsin-Yu Chen; Robert Bok; Daniel B Vigneron; Peder E Z Larson
Journal:  Magn Reson Med       Date:  2014-08-22       Impact factor: 4.668

2.  Development of high resolution 3D hyperpolarized carbon-13 MR molecular imaging techniques.

Authors:  Eugene Milshteyn; Cornelius von Morze; Galen D Reed; Hong Shang; Peter J Shin; Zihan Zhu; Hsin-Yu Chen; Robert Bok; Andrei Goga; John Kurhanewicz; Peder E Z Larson; Daniel B Vigneron
Journal:  Magn Reson Imaging       Date:  2017-01-07       Impact factor: 2.546

Review 3.  MR Molecular Imaging of Brain Cancer Metabolism Using Hyperpolarized 13C Magnetic Resonance Spectroscopy.

Authors:  Chloé Najac; Sabrina M Ronen
Journal:  Top Magn Reson Imaging       Date:  2016-10

4.  Simultaneous steady-state and dynamic 13C NMR can differentiate alternative routes of pyruvate metabolism in living cancer cells.

Authors:  Chendong Yang; Crystal Harrison; Eunsook S Jin; David T Chuang; A Dean Sherry; Craig R Malloy; Matthew E Merritt; Ralph J DeBerardinis
Journal:  J Biol Chem       Date:  2014-01-10       Impact factor: 5.157

5.  Simultaneous multiagent hyperpolarized (13)C perfusion imaging.

Authors:  Cornelius von Morze; Robert A Bok; Galen D Reed; Jan Henrik Ardenkjaer-Larsen; John Kurhanewicz; Daniel B Vigneron
Journal:  Magn Reson Med       Date:  2013-12-31       Impact factor: 4.668

6.  Simultaneous T1 and T2 mapping of hyperpolarized 13C compounds using the bSSFP sequence.

Authors:  Eugene Milshteyn; Galen D Reed; Jeremy W Gordon; Cornelius von Morze; Peng Cao; Shuyu Tang; Andrew P Leynes; Peder E Z Larson; Daniel B Vigneron
Journal:  J Magn Reson       Date:  2020-02-01       Impact factor: 2.229

7.  Handheld electromagnet carrier for transfer of hyperpolarized carbon-13 samples.

Authors:  Hong Shang; Timothy Skloss; Cornelius von Morze; Lucas Carvajal; Mark Van Criekinge; Eugene Milshteyn; Peder E Z Larson; Ralph E Hurd; Daniel B Vigneron
Journal:  Magn Reson Med       Date:  2015-03-11       Impact factor: 4.668

Review 8.  Chemistry and biochemistry of 13C hyperpolarized magnetic resonance using dynamic nuclear polarization.

Authors:  Kayvan R Keshari; David M Wilson
Journal:  Chem Soc Rev       Date:  2013-12-20       Impact factor: 54.564

Review 9.  Imaging Tumor Metabolism to Assess Disease Progression and Treatment Response.

Authors:  Kerstin N Timm; Brett W C Kennedy; Kevin M Brindle
Journal:  Clin Cancer Res       Date:  2016-09-08       Impact factor: 12.531

10.  Detection of localized changes in the metabolism of hyperpolarized gluconeogenic precursors 13 C-lactate and 13 C-pyruvate in kidney and liver.

Authors:  Cornelius von Morze; Gene-Yuan Chang; Peder E Z Larson; Hong Shang; Prasanna K R Allu; Robert A Bok; Jason C Crane; Marram P Olson; Chou T Tan; Irene Marco-Rius; Sarah J Nelson; John Kurhanewicz; David Pearce; Daniel B Vigneron
Journal:  Magn Reson Med       Date:  2016-04-21       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.